MAPT and Alzheimer disease: It is believed that an imbalance between production and clearance of β-amyloid is the triggering event and is the key factor responsible for other abnormalities observed in AD (Cummings et al., 2007; Yan, 2017), while tau protein arises as a secondary pathogenic event that subsequently worsens neurodegeneration (Roberson et al., 2007).